Eli Lilly and Company
$1172.27-6.84Market Cap
$1.08T
Global Rank
#11
All-Time High
$1.10T
2026-07-07
Total Growth
+0%
since 2026
Market Cap Context
- Larger than 97% of the 367 companies we track (globally).
- Equivalent to 3.5% of United States's GDP (2025 data).
- Just above: #10 Tesla, Inc. ($1.31T)
- Just below: #12 Samsung Electronics Co., Ltd. ($994.0B)
- Best year: 1997 (+94%). Worst year: 1999 (-24%).
Eli Lilly and Company Financial Breakdown (FY 2025)
Source: Yahoo Finance โ LLY annual filings (2025) โ$65.2B revenue ยท $29.7B operating income ยท $20.6B net income
- โOperating margin: 45.6% on $65.2B in revenue.
- โR&D is 20.5% of revenue ($13.3B).
- โNet income margin: 31.7% โ $20.6B in profit.
- โFree cash flow: $6.0B (9.2% of revenue).
Cost / Operating Expenses
Total operating expenses $35.5B
Total
$35.5B
Capital Expenditures
$10.8B
This fiscal year (near-total AI infrastructure buildout)
Free Cash Flow
$6.0B
Trailing twelve months
Figures rounded from the annual SEC filing. Unaudited. For informational purposes only, not investment advice.
Fundamentals (TTM)
Data: Financial Modeling PrepP/E
โ
EPS
โ
Net margin
โ
ROE
โ
Dividend yield
โ
Debt / Equity
โ
About Eli Lilly and Company
Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by Eli Lilly, a pharmaceutical chemist and Union army veteran during the American Civil War for whom the company was later named.
Eli Lilly and Company Market Cap History (2026โ2026)
Eli Lilly and Company vs Sector Peers by Market Cap
Compare Eli Lilly and Company
Ranking History
| Year | Market Cap | Rank | YoY Change |
|---|---|---|---|
| 2026 | $1.08T | #11 | +13.4% |
| 2025 | $955.1B | #11(โ1) | +40.2% |
| 2024 | $681.0B | #12(โ1) | +33.3% |
| 2023 | $510.9B | #11(โ8) | +60.9% |
| 2022 | $317.5B | #19(โ16) | +34.3% |
| 2021 | $236.5B | #35(โ17) | +66.1% |
| 2020 | $142.4B | #52(โ10) | +31.0% |
| 2019 | $108.7B | #62(โ12) | +16.1% |
| 2018 | $93.6B | #50(โ23) | +40.5% |
| 2017 | $66.6B | #73 | +17.8% |
| 2016 | $56.5B | #73(โ11) | -10.4% |
| 2015 | $63.1B | #62(โ9) | +25.4% |
| 2014 | $50.3B | #71(โ24) | +39.8% |
| 2013 | $36.0B | #95(โ23) | +7.3% |
| 2012 | $33.5B | #72(โ2) | +24.2% |
| 2011 | $27.0B | #74(โ33) | +25.2% |
| 2010 | $21.6B | #107(โ18) | +3.7% |
| 2009 | $20.8B | #89(โ28) | -6.2% |
| 2008 | $22.2B | #61(โ17) | -21.3% |
| 2007 | $28.2B | #78(โ13) | +5.7% |
| 2006 | $26.7B | #65(โ10) | -5.2% |
| 2005 | $28.1B | #55(โ10) | +2.5% |
| 2004 | $27.5B | #45(โ13) | -17.5% |
| 2003 | $33.3B | #32(โ2) | +13.1% |
| 2002 | $29.4B | #30 | -17.6% |
| 2001 | $35.7B | #30(โ2) | -14.4% |
| 2000 | $41.7B | #32(โ9) | +41.9% |
| 1999 | $29.4B | #41(โ15) | -24.2% |
| 1998 | $38.8B | #26(โ2) | +29.1% |
| 1997 | $30.1B | #24(โ12) | +93.5% |
| 1996 | $15.5B | #36(โ6) | +32.7% |
| 1995 | $11.7B | #30(โ1) | +77.3% |
| 1994 | $6.6B | #31 |
Other Healthcare Companies
FAQ
What is Eli Lilly and Company's market cap?
Eli Lilly and Company (LLY) has a market capitalization of $1.08T, making it the #11 largest company in the world by market cap.
What was Eli Lilly and Company's highest market cap?
Eli Lilly and Company's all-time high market cap was $1.10T, reached in 2026-07-07. Its highest rank was #11 in 2026.
What sector is Eli Lilly and Company in?
Eli Lilly and Company is in the Healthcare sector, specifically the Drug Manufacturers - General industry. It is based in United States.
How has Eli Lilly and Company's market cap changed over time?
Eli Lilly and Company has been tracked since 2026. Its market cap has grown by 0% from $1.08T in 2026 to $1.08T today.